Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Can-Fite Biopharma Ltd Sponsored ADR (Israel)
(NY:
CANF
)
0.3130
-0.0260 (-7.67%)
Official Closing Price
Updated: 8:00 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Can-Fite Biopharma Ltd Sponsored ADR (Israel)
< Previous
1
2
3
4
5
6
7
Next >
In today's session, these stocks are experiencing unusual volume.
↗
November 19, 2025
Let's explore the current happenings on the US markets on Wednesday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Via
Chartmill
Tuesday's after hours session: top gainers and losers
↗
November 18, 2025
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
Which stocks are most active on Tuesday?
↗
November 18, 2025
Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume!
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
November 18, 2025
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
Dow Falls Over 300 Points; Home Depot Posts Downbeat Earnings
↗
November 18, 2025
Via
Benzinga
Topics
Stocks
These stocks that are showing activity before the opening bell on Tuesday.
↗
November 18, 2025
As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 18, 2025
Via
Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
↗
September 30, 2025
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
August 22, 2025
Via
Benzinga
Top movers in Monday's session
↗
July 28, 2025
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
July 28, 2025
Via
Benzinga
bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
March 28, 2025
Via
ACCESS Newswire
Unusual volume stocks in Thursday's session
↗
March 20, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
March 19, 2025
Via
Benzinga
60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
November 22, 2024
Via
ACCESSWIRE
OS Therapies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
August 09, 2024
Via
ACCESSWIRE
Positive Results from Osteoarthritis Clinical Study in Dogs Reported by Can-Fite’s Partner Vetbiolix
June 28, 2024
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite: Breakthrough Findings Demonstrate Namodenoson Anti-cancer and Protective Effect Mechanism in the Liver
June 24, 2024
From
Can-Fite BioPharma Ltd.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
June 14, 2024
Via
Benzinga
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
June 14, 2024
Via
Benzinga
Can-Fite Received IRB Approval for the Treatment of Pancreatic Cancer with Namodenoson in a Phase IIa Study
June 10, 2024
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study
June 05, 2024
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic Effects on Heart Diseases
May 29, 2024
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite to Participate in Partnering Meetings at Bio International Convention 2024
May 27, 2024
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on June 6
May 23, 2024
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite: 75 Oncologists and Coordinators from Europe US and Israel Participated in a Conference Aimed at Accelerating Patient Enrolment for the Pivotal Phase 3 Advanced Liver Cancer Study
May 13, 2024
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
May 10, 2024
Via
ACCESSWIRE
Can-Fite: FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study
May 09, 2024
From
Can-Fite BioPharma Ltd.
Via
Business Wire
Can-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602
May 06, 2024
From
Can-Fite BioPharma Ltd.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
